Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koch Separation Solutions (KSS) is a global leader in separation technologies, specializing in membrane filtration, ion exchange, evaporation, and distillation. The company provides critical equipment and process solutions for the life sciences, food and beverage, and industrial water markets. In the biopharmaceutical sector, KSS is a prominent provider of downstream processing technologies used for the purification of monoclonal antibodies, vaccines, and recombinant proteins. Their product portfolio includes well-known brands such as ROMICON and PURON, which are essential for cell culture clarification and protein concentration. Formerly a part of Koch Industries, KSS was acquired by Ion Exchange (India) Limited in 2023. The company continues to operate as a specialized technology provider, helping manufacturers improve yield and efficiency in complex separation processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koch Separation Systems.